Diabetes mellitus type 1 surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:


==Overview==
==Overview==
Surgery is not the first-line treatment option for patients with type 1 DM. β-Cell Replacement Therapy  is usually reserved for patients with either who have an indication for kidney transplantation and are poorly controlled with large glycemic excursions or in patients who already receieved a kidney transplant.
Surgery is not the first-line treatment option for patients with type 1 DM. β-Cell Replacement Therapy  is usually reserved for patients with either who have an indication for kidney transplantation and are poorly controlled with large glycemic excursions or in patients who already received a kidney transplant.


==Surgery==
==Surgery==

Revision as of 15:55, 7 March 2017

Diabetes mellitus main page

Diabetes mellitus type 1 Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Classification

Causes

Differentiating Diabetes mellitus type 1 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Dietary Management

Medical Therapy

Surgery

Strategies for Improving Care

Foundations of Care and Comprehensive Medical Evaluation

Diabetes Self-Management, Education, and Support
Nutritional Therapy

Glycemic Targets

Approaches to Glycemic Treatment

Cardiovascular Disease and Risk Management

Hypertension and Blood Pressure Control
Lipid Management
Antiplatelet Agents
Coronary Heart Disease

Microvascular Complications and Foot Care

Diabetic Kidney Disease
Diabetic Retinopathy
Diabetic Neuropathy
Diabetic Footcare

Older Adults with Diabetes

Children and Adolescents with Diabetes

Management of Cardiovascular Risk Factors in Children and Adolescents with Diabetes
Microvascular Complications in Children and Adolescents with Diabetes

Management of Diabetes in Pregnancy

Diabetes Care in the Hospital Setting

Primary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Diabetes mellitus Main page

Patient Information

Type 1
Type 2

Overview

Classification

Diabetes mellitus type 1
Diabetes mellitus type 2
Gestational diabetes

Differential Diagnosis

Complications

Screening

Diagnosis

Prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]Vishal Devarkonda, M.B.B.S[4]

Overview

Surgery is not the first-line treatment option for patients with type 1 DM. β-Cell Replacement Therapy is usually reserved for patients with either who have an indication for kidney transplantation and are poorly controlled with large glycemic excursions or in patients who already received a kidney transplant.

Surgery

Bariatric Surgery

The role of bariatric surgery in patients with type 1 diabetes mellitus who also suffer with obesity and obesity-associated comorbidities remains unclear. Patients do experience significant weight loss, co-morbidity resolution, decline in total insulin requirement after surgery. Data is insufficient to recommend any particular procedure.[1]

Artificial Pancreas

Pancreas transplantation

Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association β-Cell Replacement Therapy Recommendations 2014

"1.Consider solid organ pancreas transplantation simultaneously with kidney transplantation in patients with type 1 diabetes who have an indication for kidney transplantation and are poorly controlled with large glycemic excursions.. (Level of Evidence: B)"
"2.Consider solid organ pancreas transplantation after kidney transplantation in adult patients with type 1 diabetes who have already received a kidney transplant. (Level of Evidence: C)"
"3.Judiciously consider solid organ pancreas transplantation alone in adults with type 1 diabetes, unstable glucose control, hypoglycemia unawareness, and an increased risk of diabetes-related mortality, who have attempted all of the more traditional approaches to glycemic control and have remained unsuccessful, yet are judged responsible enough to manage the antirejection medication regimen, risks, and follow-up required with an organ transplant. (Level of Evidence: C)"
"4. Consider referral to research centers for protocolized islet cell transplantation in patients with type 1 diabetes and debilitating complications of diabetes who are interested in research possibilities and fit the criteria for the research protocol.(Level of Evidence: E)"

References

  1. Mahawar KK, De Alwis N, Carr WR, Jennings N, Schroeder N, Small PK (2016). "Bariatric Surgery in Type 1 Diabetes Mellitus: A Systematic Review". Obes Surg. 26 (1): 196–204. doi:10.1007/s11695-015-1924-z. PMID 26452482.

Template:WH Template:WS